Literature DB >> 33401674

Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.

Fanni Tóth1, Edina Katalin Cseh1, László Vécsei1,2.   

Abstract

The incidence of neurodegenerative diseases has increased greatly worldwide due to the rise in life expectancy. In spite of notable development in the understanding of these disorders, there has been limited success in the development of neuroprotective agents that can slow the progression of the disease and prevent neuronal death. Some natural products and molecules are very promising neuroprotective agents because of their structural diversity and wide variety of biological activities. In addition to their neuroprotective effect, they are known for their antioxidant, anti-inflammatory and antiapoptotic effects and often serve as a starting point for drug discovery. In this review, the following natural molecules are discussed: firstly, kynurenic acid, the main neuroprotective agent formed via the kynurenine pathway of tryptophan metabolism, as it is known mainly for its role in glutamate excitotoxicity, secondly, the dietary supplement pantethine, that is many sided, well tolerated and safe, and the third molecule, α-lipoic acid is a universal antioxidant. As a conclusion, because of their beneficial properties, these molecules are potential candidates for neuroprotective therapies suitable in managing neurodegenerative diseases.

Entities:  

Keywords:  Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; kynurenic acid; kynurenine pathway; multiple sclerosis; neurodegenerative diseases; neuroprotection; pantethine; α-lipoic acid

Mesh:

Substances:

Year:  2021        PMID: 33401674      PMCID: PMC7795784          DOI: 10.3390/ijms22010403

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  210 in total

1.  Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.

Authors:  H Q Wu; S C Lee; R Schwarcz
Journal:  Eur J Pharmacol       Date:  2000-03-03       Impact factor: 4.432

Review 2.  The beneficial effects of physical exercise in the brain and related pathophysiological mechanisms in neurodegenerative diseases.

Authors:  Yan Liu; Tim Yan; John Man-Tak Chu; Ying Chen; Sophie Dunnett; Yuen-Shan Ho; Gordon Tin-Chun Wong; Raymond Chuen-Chung Chang
Journal:  Lab Invest       Date:  2019-02-26       Impact factor: 5.662

3.  Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.

Authors:  A F Miranda; R J Boegman; R J Beninger; K Jhamandas
Journal:  Neuroscience       Date:  1997-06       Impact factor: 3.590

4.  Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease.

Authors:  Zsuzsanna Hartai; Peter Klivenyi; Tamas Janaky; Botond Penke; Laszlo Dux; Laszlo Vecsei
Journal:  J Neurol Sci       Date:  2005-08-15       Impact factor: 3.181

5.  The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.

Authors:  L P de Carvalho; P Bochet; J Rossier
Journal:  Neurochem Int       Date:  1996-04       Impact factor: 3.921

Review 6.  The definition and meaning of treatment-resistant depression.

Authors:  H A Sackeim
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

7.  Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model.

Authors:  Kevin Baranger; Manuel van Gijsel-Bonnello; Delphine Stephan; Wassila Carpentier; Santiago Rivera; Michel Khrestchatisky; Bouchra Gharib; Max De Reggi; Philippe Benech
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

8.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma.

Authors:  Gustav Mattiasson; Mehrdad Shamloo; Gunilla Gido; Kavitha Mathi; Gregor Tomasevic; Saili Yi; Craig H Warden; Roger F Castilho; Thorsten Melcher; Mirella Gonzalez-Zulueta; Karoly Nikolich; Tadeusz Wieloch
Journal:  Nat Med       Date:  2003-07-13       Impact factor: 53.440

Review 9.  Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.

Authors:  B Wirleitner; G Neurauter; K Schröcksnadel; B Frick; D Fuchs
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

Review 10.  Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.

Authors:  Gelareh Mazarei; Blair R Leavitt
Journal:  J Huntingtons Dis       Date:  2015
View more
  7 in total

1.  A Set of Dysregulated Target Genes to Reduce Neuroinflammation at Molecular Level.

Authors:  Marcella Massimini; Benedetta Bachetti; Elena Dalle Vedove; Alessia Benvenga; Francesco Di Pierro; Nicola Bernabò
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

2.  Identification of Human Brain Proteins for Bitter-Sweet Taste Perception: A Joint Proteome-Wide and Transcriptome-Wide Association Study.

Authors:  Wenming Wei; Bolun Cheng; Dan He; Yijing Zhao; Xiaoyue Qin; Qingqing Cai; Na Zhang; Xiaoge Chu; Sirong Shi; Feng Zhang
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

3.  Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus.

Authors:  Theresa S Rimmele; Shaomin Li; Jens Velde Andersen; Emil W Westi; Alexander Rotenberg; Jianlin Wang; Blanca Irene Aldana; Dennis J Selkoe; Chiye J Aoki; Chris G Dulla; Paul Allen Rosenberg
Journal:  Front Cell Neurosci       Date:  2021-12-29       Impact factor: 5.505

Review 4.  Neurological Infection, Kynurenine Pathway, and Parasitic Infection by Neospora caninum.

Authors:  Ana Elisa Del'Arco; Deivison Silva Argolo; Gilles Guillemin; Maria de Fátima Dias Costa; Silvia Lima Costa; Alexandre Moraes Pinheiro
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

5.  Genome-wide association study of stimulant dependence.

Authors:  Jiayi Cox; Richard Sherva; Leah Wetherill; Tatiana Foroud; Howard J Edenberg; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer
Journal:  Transl Psychiatry       Date:  2021-06-29       Impact factor: 6.222

6.  Neuroprotective Effect of Gallocatechin Gallate on Glutamate-Induced Oxidative Stress in Hippocampal HT22 Cells.

Authors:  Do Hwi Park; Jun Yeon Park; Ki Sung Kang; Gwi Seo Hwang
Journal:  Molecules       Date:  2021-03-04       Impact factor: 4.411

7.  Experience with nutraceutical supplements in the treatment of pelvic pain in gynaecology: case reports.

Authors:  Francisco Nohales Alfonso
Journal:  Drugs Context       Date:  2022-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.